Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gurion, Ronit"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Schuster M; Stony Brook University Hospital Cancer Center, Stony Brook, NY. Electronic address: Michael.Schuster@stonybrookmedicine.edu., Zijlstra J; Amsterdam UMC, Vrije Universiteit, Cancer Center, Amsterdam, Netherlands., Casasnovas RO; Hématologie Clinique and INSERM 1231, Dijon, France., Vermaat JSP; LUMC, Leiden, Netherlands., Kalakonda N; University of Liverpool, Liverpool, United Kingdom., Goy A; Hackensack University Medical Center, Hackensack, NJ, United States., Choquet S; Hôpital Pitié Salpêtrière, Paris, France., Neste EVD; Cliniques Universitaires Saint-Luc, Brussels, Belgium., Hill B; Cleveland Clinic, Cleveland, OH, United States., Thieblemont C; APHP, Saint-Louis Hospital, Hemato-oncology, Paris, France & Diderot University, Paris, France., Cavallo F; University of Torino, Turin, Italy., De la Cruz F; Hospital Universitario Virgen del Rocio, Sevilla, Spain., Kuruvilla J; Princess Margaret Cancer Centre, Toronto, Canada., Hamad N; St. Vincent's Hospital Sydney, Darlinghurst, Australia., Jaeger U; Medical University of Vienna, Vienna, Austria., Caimi P; UH Seidman Cancer Center, Cleveland, OH, United States., Gurion R; Rabin MC, Petah Tiqwa, Israel., Warzocha K; Instytut Hematologii i Transfuzjologii, Warszawa, Poland., Bakhshi S; Dr. B. R. A. Institute Rotary Cancer Hospital, New Delhi, India., Sancho JM; Hospital Universitari Germans Trias I Pujol, Barcelona, Spain., Follows G; Addenbrooke's Hospital, Cambridge, United Kingdom., Egyed M; Teaching Hospital Mór Kaposi, Kaposvár, Hungary., Offner F; UZ Gent, Gent, Belgium., Vassilakopoulos T; Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece., Samal P; Institute of Medical Sciences & SUM Hospital, Odisha, India., Ku M; St.Vincent's Hospital Melbourne, Fitzroy, Australia., Ma X; Karyopharm Therapeutics, Newton, MA, United States., Corona K; Karyopharm Therapeutics, Newton, MA, United States., Chamoun K; Karyopharm Therapeutics, Newton, MA, United States., Shah J; Karyopharm Therapeutics, Newton, MA, United States., Shacham S; Karyopharm Therapeutics, Newton, MA, United States., Kauffman MG; Karyopharm Therapeutics, Newton, MA, United States., Canales M; Hospital Universitario La Paz, Madrid, Spain., Maerevoet M; Institut Jules Bordet, Brussels, Belgium.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Jul; Vol. 22 (7), pp. 483-494. Date of Electronic Publication: 2021 Dec 25.
Autor:
Casasnovas RO; Hématologie Clinique and INSERM 1231, CHU Dijon Bourgogne, Dijon, France. Electronic address: olivier.casasnovas@chu-dijon.fr., Follows G; Addenbrooke's Hospital, Cambridge, United Kingdom., Zijlstra JM; Amsterdam University Medical Center, Vrije Universiteit, Cancer Center, Amsterdam, The Netherlands., Vermaat JSP; Leiden University Medical Center, Leiden, The Netherlands., Kalakonda N; University of Liverpool, Liverpool, United Kingdom., Choquet S; Hôpital Pitié Salpêtrière, Paris, France., Neste EVD; Cliniques Universitaires Saint-Luc, Brussels, Belgium., Hill B; Cleveland Clinic, Cleveland, OH., Thieblemont C; AP-HP, Hopital Saint-Louis, Hémato-oncology, DMU DHI, Paris, France; Université de Paris, Paris, France., Cavallo F; Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Turin, Turin, Italy., la Cruz F; Hospital Universitario Virgen del Rocio, Sevilla, Spain., Kuruvilla J; Princess Margaret Cancer Center, Toronto, Canada., Hamad N; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia., Jaeger U; Medical University of Vienna, Vienna, Austria., Caimi PF; UH Seidman Cancer Center, Cleveland, OH., Gurion R; Institute of Hematology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Warzocha K; Instytut Hematologii i Transfuzjologii, Warsaw, Poland., Bakhshi S; Dr. B. R. A. Institute Rotary Cancer Hospital, New Delhi, India., Sancho JM; Hospital Universitari Germans Trias I Pujol, Barcelona, Spain., Schuster M; Stony Brook University Hospital Cancer Center, New York, NY., Egyed M; Teaching Hospital Kaposi Mór, Kaposvár, Hungary., Offner F; Ghent University Hospital, Ghent, Belgium., Vassilakopoulos TP; Department of Haematology, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece., Samal P; Institute of Medical Sciences & SUM Hospital, Odisha, India., Ku M; St.Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia., Ma X; Karyopharm Therapeutics, Newton, MA., Chamoun K; Karyopharm Therapeutics, Newton, MA., Shah J; Karyopharm Therapeutics, Newton, MA., Canales M; Hospital Universitario La Paz, Madrid, Spain., Maerevoet M; Institute Jules Bordet, Brussels, Belgium., Shacham S; Karyopharm Therapeutics, Newton, MA., Kauffman MG; Karyopharm Therapeutics, Newton, MA., Goy A; Hackensack University Medical Center, Hackensack, NJ.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Jan; Vol. 22 (1), pp. 24-33. Date of Electronic Publication: 2021 Jul 22.
Autor:
Gurion R; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: ronitgurion@gmail.com., Bernstine H; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Department of Nuclear Medicine, Rabin Medical Center, Petah-Tikva, Israel., Domachevsky L; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Department of Nuclear Medicine, Rabin Medical Center, Petah-Tikva, Israel., Michelson C; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Raanani P; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Vidal L; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Shochat T; Bio-Statistical Unit, Rabin Medical Center, Petah-Tikva, Israel., Gafter-Gvili A; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Medicine A, Rabin Medical Center, Petah-Tikva, Israel.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2018 Oct; Vol. 18 (10), pp. 687-691. Date of Electronic Publication: 2018 Jun 27.
Autor:
Shargian-Alon L; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: liatshar@gmail.com., Gurion R; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Raanani P; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Yahav D; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Infectious Disease Unit, Rabin Medical Center, Petah-Tikva, Israel., Gafter-Gvili A; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Department of Internal Medicine A, Rabin Medical Center, Petah-Tikva, Israel.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2018 Sep; Vol. 18 (9), pp. 603-610.e1. Date of Electronic Publication: 2018 May 28.